You are viewing: China Intraocular Lens Market analysis
Part of: Intraocular Lens Market (Global)

The China Intraocular Lens Market was valued at $259.6 Million in 2025 and projected to reach to $364.3 Million by 2030, representing a compound annual growth rate of 7.0%. China's intraocular lens market is poised for sustained expansion driven by demographic pressures and healthcare modernization.

China Intraocular Lens Market (2025-2030) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

China Intraocular Lens Market Trends and Insights

  • This 7.0% compound annual growth rate reflects China's aging population, rising prevalence of cataracts, and increasing healthcare spending on ophthalmic procedures.
  • China's market expansion is driven by improved access to cataract surgery in both urban and rural regions, supported by government healthcare initiatives and growing private hospital networks. The intraocular lens sector in China benefits from technological advancement and the introduction of premium lens options, including multifocal and toric designs.
  • China's manufacturing capabilities and cost-competitive production have positioned the country as both a significant consumer and supplier within the Asia Pacific region.
  • Between 2025 and 2030, China is expected to see accelerated adoption of advanced IOL technologies as disposable incomes rise and patient awareness improves. China's regulatory environment continues to evolve, with streamlined approval processes for ophthalmic devices enhancing market entry for both domestic and international manufacturers.
  • The competitive landscape in China remains dynamic, with local players gaining market share alongside established global brands..

Key Market Statistics

  • CAGR (2025-2030) 7.0% CAGR
  • Market Size, 2025 ~USD 259.6 Million
  • Forecast, 2030 ~USD 364.3 Million
  • Country China

China Intraocular Lens Market Overview

Market Valuation & Growth :

China's intraocular lens market is valued at USD 259.6 million in 2025, with a projected CAGR of 7.0% through 2030, reaching USD 364.3 million. This growth rate outpaces the global average of 6%, positioning China as a high-growth market in the Asia-Pacific region.

Aging Population Dynamics :

China's rapidly aging demographic, with over 280 million people aged 60 and above, is driving increased cataract prevalence. This demographic shift creates sustained demand for intraocular lens procedures and premium lens technologies across urban and rural healthcare settings.

Healthcare Infrastructure Expansion :

Improved access to cataract surgery in both tier-1 cities and emerging tier-2/3 markets is expanding the patient base. Government initiatives and increased private healthcare investment are enhancing surgical capacity and affordability of IOL procedures nationwide.

Rising Healthcare Expenditure :

Increasing per capita healthcare spending and growing patient awareness of vision correction options are driving adoption of advanced intraocular lens technologies, including premium multifocal and toric lenses in China's urban centers.

China Intraocular Lens Market Dynamics

  • The aging population combined with rising disposable incomes will accelerate demand for cataract surgeries and premium IOL solutions.
  • Government healthcare reforms and increased private sector participation are democratizing access to advanced ophthalmic procedures across urban and rural regions. The market will benefit from technological advancements in lens design, growing medical tourism, and enhanced reimbursement policies.
  • Competition among domestic and international manufacturers will intensify, driving innovation and price optimization.
  • By 2030, China is expected to represent a significant portion of Asia-Pacific IOL market value, with premium segment growth outpacing standard lens categories..

Related Ecosystem

Medical Devices

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Magnetic Resonance Imaging (MRI)
  • Disposable Autoinjectors
  • Pulse Oximeters
  • Blood Pressure Monitors
Top Companies
  • Medtronic plc
  • Abbott Laboratories
  • Stryker Corporation
  • Becton, Dickinson and Company
  • CONMED Corporation

    Key Takeaways

    • China's intraocular lens market is projected to grow from USD 259.6 million in 2025 to USD 364.3 million by 2030, representing a 7.0% CAGR.
    • China's aging demographic and rising cataract prevalence are primary drivers of sustained demand for IOL procedures and products.
    • Premium IOL technologies, including multifocal and toric lenses, are gaining traction in China as patient purchasing power and awareness increase.
    • China's strong manufacturing base and regulatory improvements position the country as a key hub for IOL production and innovation in Asia Pacific.

    Intraocular Lens Market Report Scope

    Report Metric Details
    Base Year 2025
    Fastest Growing Segment HYDROPHOBIC ACRYLIC IOLS (Material)
    Forecast Period 2025–2030
    Growth Rate CAGR of 6% from 2025 to 2030
    Largest Segment CATARACT SURGERY (Application)
    Market Size Base Year (Billions) ~USD 4.61 (2025)
    Revenue Forecast (Billions) ~USD 6.17 (2030)
    Segments Covered Type, Material, Application, End User

    China Intraocular Lens Market Report Segmentation

    4 segment dimensions are covered across the global market.

    By Type

    • Accommodating Iols
    • Aspheric Monofocal Iols
    • Extended Depth-Of-Focus Iols
    • Monofocal Iols
    • Multifocal Iols
    • Other Iols
    • Phakic Iols
    • Premium Iols
    • Spheric Monofocal Iols

    By Material

    • Hydrophilic Acrylic Iols
    • Hydrophobic Acrylic Iols
    • Other Materials
    • Polymethylmethacrylate
    • Silicone Iols

    By Application

    • Cataract Surgery
    • Corneal Disorders
    • Other Applications
    • Presbyopia

    By End User

    • Eye Research Institutes
    • Hospitals
    • Ophthalmology Clinics
    • Other End Users

    CHINA: INTRAOCULAR LENS MARKET, BY END USER, 2023–2030

    Segment20232024202520262027202820292030CAGR (%)
    EYE RESEARCH INSTITUTES23.925.126.427.829.43132.734.65.5
    HOSPITALS315.1336.7360.1385.7413.3443.2475.6510.87.2
    OPHTHALMOLOGY CLINICS4648.851.955.258.862.666.871.26.6
    OTHERS17.217.918.619.420.321.122.123.14.4
    TOTAL402.2428.5457.1488.1521.7557.9597.2639.87

    Target Audience

    • Medical Device Manufacturers : IOL manufacturers and ophthalmic device companies need China-specific market data to assess market entry feasibility, competitive positioning, and revenue potential in Asia's largest healthcare market with high growth trajectory.
    • Healthcare Investors & PE Firms : Investment professionals require detailed China IOL market analysis to evaluate acquisition targets, portfolio company growth prospects, and exit opportunities in the high-growth ophthalmic sector with favorable demographic tailwinds.
    • Hospital & Surgical Center Operators : Healthcare facility administrators need market insights to plan cataract surgery capacity expansion, IOL procurement strategies, and service line development aligned with growing patient demand across Chinese regions.
    • Distributors & Supply Chain Partners : Medical device distributors and logistics providers require market forecasts to optimize inventory management, distribution network planning, and partnership strategies for IOL products across China's diverse healthcare infrastructure.
    • Government & Policy Makers : Healthcare policy officials and government agencies need market data to inform reimbursement policies, healthcare infrastructure planning, and initiatives addressing cataract treatment accessibility in China's aging society.

    Key Companies in the China Intraocular Lens Market

    CompanyHQOwnershipStrongest segments
    HALMA PLCUnited KingdomPublic CompanySafety,Environmental & Analysis,Healthcare,
    FLUOR CORPORATIONUnited States
    LUMENIS LTDIsraelPrivate CompanySurgical (urology/ENT),Ophthalmic,Aesthetic,
    LENSTEC, INC.ChinaPublic CompanySmartphone glass covers and appearance structures,Functional modules (fingerprint, touch, biometrics),Smart wearables components,
    BVIUnited StatesPrivate CompanyCataract surgery instruments and consumables,Vitreoretinal surgery tools and accessories,Refractive and diagnostic accessories,

    HALMA PLC

    Halma PLC is a United Kingdom-based public company founded in 1894 that employs approximately 9,000 people. The company operates as an established industrial and safety-focused enterprise with a long history of operations.

    FLUOR CORPORATION

    Fluor Corporation is a United States-based company providing engineering, procurement, and construction services across multiple industries.

    LUMENIS LTD

    Lumenis Ltd is an Israeli private company founded in 1991 with 954 employees, specializing in laser and light-based medical technologies.

    LENSTEC, INC.

    Lenstec, Inc. is a China-based public company founded in 1993 with approximately 145,683 employees operating in the optical and lens manufacturing sector.

    BVI

    BVI is a United States-based private company founded in 1985 providing ophthalmic surgical instruments and equipment.

    Reasons to Buy this Report

    • Market Size & Growth Validation : Obtain precise market valuation data for China's IOL sector with verified CAGR of 7.0% through 2030. Validate investment decisions and revenue projections with authoritative market sizing specific to China's healthcare landscape.
    • Demographic & Clinical Insights : Access detailed analysis of China's aging population impact on cataract prevalence and surgical demand. Understand patient demographics, disease burden, and treatment patterns to tailor product positioning and market entry strategies.
    • Regional Market Segmentation : Identify growth opportunities across China's tier-1, tier-2, and tier-3 cities with differentiated healthcare infrastructure. Develop targeted go-to-market strategies based on regional healthcare spending capacity and surgical facility distribution.
    • Competitive Landscape Intelligence : Benchmark against domestic and international competitors operating in China's IOL market. Understand market consolidation trends, pricing strategies, and distribution channels specific to Chinese healthcare regulations and procurement practices.
    • Strategic Planning & Risk Mitigation : Evaluate regulatory environment, reimbursement policies, and healthcare reform initiatives affecting IOL adoption in China. Identify market entry barriers, partnership opportunities, and long-term growth catalysts for informed business strategy.

    Frequently asked questions

    What is the current size of China's intraocular lens market?

    China's intraocular lens market was valued at USD 259.6 million in 2025 and is expected to reach USD 364.3 million by 2030.

    What is the projected growth rate for China's IOL market?

    China's intraocular lens market is projected to grow at a compound annual growth rate (CAGR) of 7.0% from 2025 to 2030.

    What factors are driving growth in China's intraocular lens market?

    Key drivers include China's aging population, rising cataract prevalence, increased healthcare spending, improved surgical access in rural areas, and growing adoption of premium IOL technologies.

    Which types of intraocular lenses are gaining popularity in China?

    Premium IOL options such as multifocal and toric lenses are increasingly popular in China as patient awareness and disposable incomes rise.

    How does China's IOL market compare to the global market?

    China's 7.0% CAGR outpaces the global intraocular lens market CAGR of 6.0%, reflecting stronger regional growth dynamics and demographic trends.

    RESEARCH METHODOLOGY

    The study involved major activities in estimating the current market size for the intraocular lens market. Exhaustive secondary research was done to collect information on the intraocular lens market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain using primary research. Different approaches, including top-down and bottom-up methods, were employed to estimate the total market size. After that, the market breakup and data triangulation procedures were used to estimate the market size of the segments and subsegments of the intraocular lens market.

    Secondary Research

    This research study involved the extensive use of secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as whitepapers and company house documents. Secondary research was undertaken to identify and collect information for this extensive, technical, market-oriented, and commercial study of the intraocular lens market. It was also used to obtain important information about top players, market classification, and segmentation according to industry trends, as well as geographic markets and key developments related to the market. A database of the key industry leaders was also prepared using secondary research.

    Primary Research

    In the primary research process, various supply- and demand-side sources were interviewed to obtain qualitative and quantitative information for this report. Primary sources from the supply side included industry experts such as CEOs, VPs/managing directors, marketing heads/directors and sales directors, marketing/sales managers, regional/area sales managers, export/import heads/managers, and other ophthalmic market-related personnel from various companies and organizations operating in the intraocular lens market. Primary sources from the demand side included the vice presidents of hospitals and clinics, C-level executives, department heads, doctors/eye physicians, supply management teams of hospitals, clinic personnel, and laboratory technicians.

    Breakdown of Primary Interviews

    Intraocular Lens Market

    Note 1: C-level executives include CEOs, COOs, and CTOs.

    Note 2: Others include sales, marketing, and product managers.

    Note 3: Companies are classified into tiers based on their total revenue. As of 2024: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, Tier 3 = < USD 500 million

    To know about the assumptions considered for the study, download the pdf brochure

    Market Size Estimation

    Both top-down and bottom-up approaches were used to estimate and validate the total size of the intraocular lens market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

    Intraocular Lens Market

    Data Triangulation

    The entire market was split into four segments when the market size was determined. Data triangulation and market breakdown processes were used where necessary to complete the entire market engineering process and arrive at precise statistics for all segments.

    Approach to derive the market size and estimate market growth.

    Using secondary data from paid and unpaid sources, the market rankings for the major players were determined following a thorough analysis of their sales of intraocular lenses. Due to data restrictions, the revenue share in certain cases was determined after a thorough analysis of the product portfolio of big corporations and their individual sales performance. This information was verified at each stage by in-depth interviews with professionals in the field.

    Market Definition

    Intraocular lenses, or IOLs, refer to artificial lenses that are implanted in the eye, usually during cataract surgery or for other problems with vision. These lenses are made of biocompatible materials like silicone or acrylic and are intended to replace the natural lens of the eye that has been clouded by cataracts or to improve focusing ability for clearer vision. IOLs are available in several types: monofocal lenses, which provide clear vision at a single distance (near or far); multifocal lenses, which correct the vision at numerous distances; toric lenses, which correct astigmatism; and accommodating lenses, which replicate the focusing capacity of a natural lens.

    Stakeholders

    • Manufacturers of Intraocular Lenses
    • Eye Research Institutions
    • Contract Manufacturing Organizations (CMOs)
    • Government Associations
    • Market Research and Consulting Firms
    • Venture Capitalists and Investors
    • Distributors of Intraocular Lenses
    • Ophthalmic Device Research & Development (R&D) Companies
    • Ophthalmology Hospitals & Clinics

    Report Objectives

    • To describe, analyze, and forecast the intraocular lens market by type, material, application, end user, and region
    • To describe and forecast the intraocular lens market for key regions: North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa, and the GCC Countries
    • To provide detailed information regarding drivers, restraints, opportunities, and challenges influencing the growth of the intraocular lens market
    • To strategically analyze the ecosystem, regulations, patenting trend, value chain, Porter’s five forces, and prices pertaining to the market under study
    • To strategically analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
    • To analyze market opportunities for stakeholders and provide details of the competitive landscape for market players
    • To profile key players and comprehensively analyze their market shares and core competencies in the intraocular lens market
    • To analyze competitive developments such as collaborations, acquisitions, product launches, expansions, and R&D activities in the intraocular lens market

    Get the Full Intraocular Lens Market Report

    Full forecast, segment splits, and company analysis for all Intraocular Lens Market.

    Need a Tailored Report?

    Customize this report to your needs

    Get 10% FREE Customization

    Customize This Report
    Fact checked
    DMCA.com Protection Status